Skip to main content
. 2019 Mar 28;30(2):193–200. doi: 10.1007/s13337-019-00517-6

Fig. 2.

Fig. 2

The association between high expression of GPC3 and DFS in patients with HCC. DFS was reported in 7 studies with a total of 829 HCC patients. Because of the heterogeneity in the study, pooled HR was calculated by the random effect model. The summary HR and 95% CIs were shown. CI confidence interval, GPC3 glypican-3, HCC hepatocellular carcinoma, HR hazard ratio